Literature DB >> 15728162

Cocaine and phenylephrine eye drop test for Parkinson disease.

Hideyuki Sawada, Kentarou Yamakawa, Hodaka Yamakado, Ryohei Hosokawa, Muneo Ohba, Kazuaki Miyamoto, Takashi Kawamura, Shun Shimohama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15728162     DOI： 10.1001/jama.293.8.932-c

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

2.  Pupillary autonomic dysfunction in multiple system atrophy and Parkinson's disease: an assessment by eye-drop tests.

Authors:  Fumitada Yamashita; M Hirayama; T Nakamura; M Takamori; N Hori; K Uchida; T Hama; Gen Sobue
Journal:  Clin Auton Res       Date:  2010-02-03       Impact factor: 4.435

3.  Pupillary supersensitivity and visual disturbance in Parkinson's disease.

Authors:  Norio Hori; Motoko Takamori; Masaaki Hirayama; Hirohisa Watanabe; Tomohiko Nakamura; Fumitada Yamashita; Hiroki Ito; Naoki Mabuchi; Gen Sobue
Journal:  Clin Auton Res       Date:  2008-02-11       Impact factor: 4.435

4.  Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.

Authors:  Atsushi Umemura; Tomoko Oeda; Ryutaro Hayashi; Satoshi Tomita; Masayuki Kohsaka; Kenji Yamamoto; Hideyuki Sawada
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

Review 5.  Catecholamines and Neurodegeneration in Parkinson's Disease-From Diagnostic Marker to Aggregations of α-Synuclein.

Authors:  Hideyuki Sawada; Tomoko Oeda; Kenji Yamamoto
Journal:  Diagnostics (Basel)       Date:  2013-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.